NCT04550494 2026-03-19Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair VariationsNational Cancer Institute (NCI)Phase 2 Recruiting36 enrolled
NCT02567396 2017-04-24Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney DysfunctionNational Cancer Institute (NCI)Phase 1 Withdrawn